- Previous Close
31.83 - Open
32.21 - Bid 31.80 x --
- Ask 32.00 x --
- Day's Range
31.50 - 32.56 - 52 Week Range
21.50 - 47.80 - Volume
233,702 - Avg. Volume
635,981 - Market Cap (intraday)
96.691M - Beta (5Y Monthly) 1.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.01 - Earnings Date Apr 8, 2025 - Apr 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
133.67
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
www.futuramedical.comRecent News: FUM.L
View MorePerformance Overview: FUM.L
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FUM.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FUM.L
View MoreValuation Measures
Market Cap
96.69M
Enterprise Value
92.77M
Trailing P/E
--
Forward P/E
12.50
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.71
Price/Book (mrq)
12.38
Enterprise Value/Revenue
11.05
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-44.68%
Return on Assets (ttm)
-26.59%
Return on Equity (ttm)
-47.43%
Revenue (ttm)
8.4M
Net Income Avi to Common (ttm)
-3.75M
Diluted EPS (ttm)
-0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
3.92M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3M